摘要
以2013—2017年中国医药生物制造业A股上市公司为样本,从企业经营性交易活动和金融性交易活动出发,利用负二项回归模型,对企业不同开放行为与组织二元创新活动之间的关系以及吸收能力的调节效用进行了实证研究。实证结果表明:企业采取内向开放式创新能够促进组织探索性创新和利用性创新活动;企业采取外向开放式创新会抑制组织二元创新;吸收能力在内外开放式创新获取资源对组织二元创新影响过程中发挥着正向的调节作用。
Based on the sample of A-share listed companies in China's pharmaceutical and biological manufacturing industry during 2013-2017,from the perspective of corporate business transaction activities and financial transaction activities,the negative binomial regression model is used in the analysis of the relationship between the different open behaviors of enterprises and the ambidextrous innovation activities of the organization,as well as the moderating role of absorptive capacity.The empirical results show that enterprises adopting inbound open innovation can promote organizational exploratory innovation and exploitative innovation activities,while companies adopting outbound open innovation can inhibit organizational ambidextrous innovation.The absorptive capacity plays a positive role in regulating the impact of inbound and outbound open innovation access to resources on the process of organizational ambidextrous innovation.
作者
刘志迎
支援援
吴瑞瑞
LIU Zhiying;ZHI Yuanyuan;WU Ruirui(School of Management, University of Science and Technology of China, Hefei 230026, China)
出处
《东北大学学报（社会科学版）》
CSSCI
北大核心
2021年第1期24-33,共10页
Journal of Northeastern University(Social Science)
基金
国家自然科学基金资助项目(71472172)。
关键词
技术创新
开放式创新
探索性创新
利用性创新
吸收能力
technological innovation
open innovation
exploratory innovation
exploitative innovation
absorptive capacity
